FDA panel unanimously backs expanding use of Amarin's heart drug Vascepa
November 14, 2019 at 16:13 PM EST
A panel of experts to the U.S. FDA on Thursday recommended allowing Amarin Corp Plc's fish-oil derived drug to be used as add-on therapy for reducing the chance of heart attacks and strokes in high-risk patients with cardiovascular disease.